3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
196
Triple Negative Breast Neoplasms
26
Neoplasm Metastasis
18
Breast Neoplasms, Male
13
Ovarian Neoplasms
9
Inflammatory Breast Neoplasms
9
Pancreatic Neoplasms
8
Neoplasms
7
Colorectal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
6
Stomach Neoplasms
5
Prostatic Neoplasms
4
Lung Neoplasms
4
Endometrial Neoplasms
4
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Recurrence
2
Multiple Myeloma
2
Lymphedema
2
Hematologic Neoplasms
2
Esophageal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Ovarian Epithelial
2
Brain Neoplasms
2
Uterine Neoplasms
1
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Interventions
Letrozole
5
Radiotherapy
4
Carboplatin
4
atamestane
3
Trastuzumab
3
Toremifene
3
Docetaxel
3
Cyclophosphamide
3
Chemotherapy, Adjuvant
3
Tamoxifen
2
Paclitaxel
2
Gene Expression Profiling
2
Fulvestrant
2
Estrogen Receptor Modulators
2
Capecitabine
2
Aromatase Inhibitors
2
Amplified Fragment Length Polymorphism Analysis
2
palbociclib
1
Zolpidem
1
Vorinostat
1
Vinorelbine
1
Venlafaxine Hydrochloride
1
Thiotepa
1
Taxes
1
Sugars
1
Reverse Transcriptase Polymerase Chain Reaction
1
Radiotherapy, Conformal
1
Radiosurgery
1
Radiomics
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Lobular
×
Bevacizumab
×
Breast
×
Clear all
NCT01641406
2012-07-16
NACprotocol
Auxilio Mutuo Cancer Center
Phase 2
Unknown
60 enrolled